Media headlines about Medtronic PLC (NYSE:MDT) have been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Medtronic PLC earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave press coverage about the medical technology company an impact score of 47.4849480257894 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Here are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:

Several equities research analysts recently weighed in on MDT shares. Deutsche Bank AG set a $96.00 price objective on shares of Medtronic PLC and gave the stock a “buy” rating in a report on Monday, July 31st. Morgan Stanley upped their price target on shares of Medtronic PLC from $84.00 to $86.00 and gave the company an “equal weight” rating in a report on Tuesday, May 30th. BidaskClub downgraded shares of Medtronic PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. BMO Capital Markets reissued an “outperform” rating and issued a $92.00 price target (down from $94.00) on shares of Medtronic PLC in a report on Wednesday, August 23rd. Finally, Needham & Company LLC reissued a “buy” rating and issued a $95.00 price target (up from $91.00) on shares of Medtronic PLC in a report on Thursday, May 25th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the stock. Medtronic PLC presently has a consensus rating of “Hold” and a consensus target price of $88.78.

Shares of Medtronic PLC (NYSE MDT) traded up 0.16% during trading on Tuesday, hitting $79.72. The stock had a trading volume of 4,130,854 shares. The company has a market capitalization of $108.57 billion, a price-to-earnings ratio of 26.83 and a beta of 1.02. Medtronic PLC has a 1-year low of $69.35 and a 1-year high of $89.72. The firm has a 50 day moving average of $84.48 and a 200 day moving average of $83.39.

Medtronic PLC (NYSE:MDT) last issued its quarterly earnings data on Tuesday, August 22nd. The medical technology company reported $1.12 EPS for the quarter, topping the consensus estimate of $1.08 by $0.04. The firm had revenue of $7.39 billion during the quarter, compared to the consensus estimate of $7.44 billion. Medtronic PLC had a return on equity of 12.92% and a net margin of 13.75%. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.03 earnings per share. Analysts expect that Medtronic PLC will post $4.76 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 20th. Investors of record on Friday, September 29th will be given a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.31%. The ex-dividend date of this dividend is Thursday, September 28th. Medtronic PLC’s payout ratio is 61.95%.

In other Medtronic PLC news, EVP Bryan C. Hanson sold 12,000 shares of the firm’s stock in a transaction on Monday, July 17th. The stock was sold at an average price of $88.57, for a total value of $1,062,840.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard H. Anderson bought 5,600 shares of the firm’s stock in a transaction on Wednesday, June 21st. The stock was purchased at an average cost of $88.90 per share, with a total value of $497,840.00. Following the completion of the transaction, the director now directly owns 71,910 shares of the company’s stock, valued at $6,392,799. The disclosure for this purchase can be found here. Company insiders own 0.25% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Affect Medtronic PLC (MDT) Share Price” was originally published by Watch List News and is the property of of Watch List News. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.watchlistnews.com/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-medtronic-plc-mdt-share-price/1530449.html.

Medtronic PLC Company Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Insider Buying and Selling by Quarter for Medtronic PLC (NYSE:MDT)

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.